home / stock / exel / exel articles

EXEL Articles, Exelixis Inc.

Stock Information
Company Name: Exelixis Inc.
Stock Symbol: EXEL
Market: NASDAQ
Website: exelixis.com
Menu
EXEL EXEL Quote EXEL Short EXEL News EXEL Articles EXEL Message Board
Get EXEL Alerts

News, Short Squeeze, Breakout and More Instantly...
Over $8M Bet On This Health Care Stock? Check Out These 4 Stocks Insiders Are Buying | Benzinga

Although U.S. stocks closed lower on Thursday, there were a few notable insider trades. When insiders purchase shares, it indicates their confidenc...
Director At Exelixis Sells $576K Of Stock | Benzinga

A substantial insider sell was reported on May 23, by Julie Smith, Director at Exelixis (NASDAQ:EXEL), based on the recent SEC filing. What Happene...

MacroGenics Gets Downgraded Following Disappointing Prostate Cancer Trial Results: 'We Were Surprised By Reported Deaths' | Benzinga

MacroGenics Inc (NASDAQ:MGNX) released interim data from the TAMARACK Phase 2 study of vobramitamab duocarmazine (vobra duo). TAMARA...

Around $4M Bet On This Healthcare Stock? Check Out These 4 Stocks Insiders Are Buying | Benzinga

Although U.S. stocks closed higher on Thursday, there were a few notable insider trades. When insiders purchase shares, it indicates their confiden...
Bristol Myers, Exelixis Reveal 4-Year Follow-Up Results From Cancer Treatment Study | Benzinga

Bristol Myers Squibb & Co (NYSE:BMY) and Exelixis Inc (NASDAQ:EXEL) revealed four-year follow-up results from a cancer study that compared o...

Jim Cramer Likes This 'Well-Run' Airline, Says This Entertainment Stock Has 'Balance Sheet From Hell' | Benzinga

On CNBC’s "Mad Money Lightning Round," Jim Cramer said Franco-Nevada Corporation (NYSE: FNV) is a "great diversified way to ...

Why Is $7B Valued Cancer Focused Exelixis Trading Lower Today? | Benzinga

Sunday, Exelixis Inc (NASDAQ: EXEL) provided financial guidance for fiscal year 2024 and delivered an update on its business. The co...
Why Exelixis Stock Is Trading Lower Today | Benzinga

Exelixis, Inc. (NASDAQ: EXEL) shares are trading lower on Monday after the company announced detailed results from its Phase 3 CABINET pivotal tria...

Next 10